Can HCQ Be Considered a “Safe Weapon” for COVID-19 in the Indian Population?

With no drugs currently approved for treatment and cure of COVID-19 (coronavirus disease 2019), hydroxychloroquine is one of the many first-line drugs used in the management. However, given the life-threatening adverse effects of HCQ that have been reported, its use as a prophylactic treatment remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangaraju, Pugazhenthan, Venkatesan, Nanditha, Venkatesan, Sajitha, Gurunthalingam, Meenalotchini Prakash, Thangaraju, Eswaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351559/
https://www.ncbi.nlm.nih.gov/pubmed/32838163
http://dx.doi.org/10.1007/s42399-020-00392-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351559/
https://www.ncbi.nlm.nih.gov/pubmed/32838163
http://dx.doi.org/10.1007/s42399-020-00392-z

Ejemplares similares